Takeda Pharmaceutica
4502
End-of-day quote Tokyo - 09/20
4713JPY
+0.58%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Engages in the manufacture, sale, marketing, import and export of pharmaceutical products

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs.

It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other.

The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products.

The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs.

The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products.

The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Number of employees : 27 230 people.
Sales per Businesses
20172018
JPY
(in Million)
%JPY
(in Million)
%
Prescription Drug1,568,87090.6%--
Consumer Healthcare82,5724.8%--
Other80,6074.7%--
Pharmaceutical--1,693,84095.7%
Intellectual Property Rights and Services--76,6934.3%
Sales per Regions
20172018
JPY
(in Million)
%JPY
(in Million)
%
Japan655,34437.8%580,34932.8%
United States520,16130%598,34133.8%
Europe and Canada279,69316.1%313,72317.7%
Asia112,7996.5%104,0265.9%
Latin America72,5164.2%75,6584.3%
Russia / Commonwealth of Independent States57,5503.3%68,2403.9%
Other33,9872%30,1941.7%
Managers
Name Title
Christophe Weber President, CEO & Representative Director
Costa Saroukos Chief Financial Officer
Andrew S. Plump Director, Chief Medical & Scientific Officer
Yasuhiko Yamanaka Managing Director & Head-Globalization
Masato Iwasaki Director & President-Japan Pharma Business Unit
Masahiro Sakane Independent Outside Director
Shiro Kuniya Independent Outside Director
Yoshiaki Fujimori Independent Outside Director
Emiko Higashi Independent Outside Director
Michel Orsinger Independent Outside Director
Shareholders
Name Equities %
Parametric Portfolio Associates LLC 1,729,785 0.11%
Glenmede Investment Management LP 368,960 0.023%
Pacer Advisors, Inc. 114,170 0.0072%
NorthCoast Asset Management LLC 98,803 0.0062%
FNY Capital Management LP 89,600 0.0056%
World Asset Management, Inc. 47,391 0.0030%
Kepos Capital LP 20,000 0.0013%
SEI Investments Management Corp. 18,545 0.0012%
Aperio Group LLC 18,144 0.0011%
Kayne Anderson Rudnick Investment Management LLC 15,390 0.0010%
Company contact information
1-1 Doshomachi 4-chome
JP-540-8645 Nishi-ku, Osaka
Japan

Phone : +81 6 6204 2111
Fax : +81 6 6204 2880
Internet : http://www.takeda.co.jp
Markets and indexes
- Tokyo Stock Exchange
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
Stock Exchange Codes
- ISIN Code :  JP3463000004
- Bloomberg Code :  4502:JP
- Reuters Code :  4502.T
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
TAKEDA PHARMACEUTICAL CO LTD-27.49%33 184
JOHNSON & JOHNSON0.59%376 820
PFIZER20.13%253 595
NOVARTIS-0.80%216 184
ROCHE HOLDING LTD.-4.06%211 637
MERCK AND COMPANY24.36%186 114
AMGEN16.35%131 526
ABBOTT LABORATORIES19.87%120 171
ELI LILLY AND COMPANY26.55%113 563
SANOFI4.55%109 834
BRISTOL-MYERS SQUIBB COMPANY0.33%99 218
GLAXOSMITHKLINE13.18%97 628
ASTRAZENECA9.37%93 281
NOVO NORDISK A/S-10.27%89 874
BAYER-27.67%80 647
ALLERGAN PLC13.75%63 826
CELGENE CORPORATION-16.05%61 460
SHIRE16.22%54 502
ASTELLAS PHARMA INC38.38%35 399
CHUGAI PHARMACEUTICAL CO LTD20.97%34 812
JIANGSU HENGRUI MEDICINE CO LTD11.47%31 799